Clinical Trial

A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study is a open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with CRSwNP.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-06-06
Trial Details
NCT Number NCT07483268
Lead Sponsor Chengdu Kangnuoxing Biopharma,Inc.
Conditions CRSWNP
Enrollment 600 participants
Start Date 2026-05-29
Primary Completion 2027-12 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-05